MANGALAM GLOBAL ENT LTD
MGEL · General/Diversified · NSE
₹15
Current Market Price
Fair Value (DCF)
₹23
Discount to FV
+51.8%
Updated just now
YieldIQ Score
40/100
Piotroski F-Score
6/9
Economic Moat
None
Confidence
39%
ROE
18.2%
Debt/Equity
0.87
WACC
11.1%
Market Cap
₹494.33 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
19.0%
Return on capital employed
EV / EBITDA
10.1×
Enterprise multiple
Debt / EBITDA
3.5×
Leverage vs earnings
Interest Coverage
2.1×
EBIT covers interest
Current Ratio
1.46×
Short-term liquidity
Asset Turnover
5.19×
Revenue per ₹ of assets
Revenue CAGR (3Y)
34.0%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹15
Bear case
Discount -5.8%
Base case
Discount +34.1%
Bull case
Discount +56.1%
Ratio Trends
MGEL · last 6 annual periods
ROE
18.2%
ROCE
19.0%
Operating Margin
—
Debt / Equity
0.87×
PE
18.8×
EV / EBITDA
14.5×
Historical Financials
MGEL · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1277 Cr | ₹1406 Cr | ₹1818 Cr | ₹2281 Cr | ₹3384 Cr | +27.6% |
| EBITDA | ₹18.5 Cr | ₹32.6 Cr | ₹50.1 Cr | ₹63.5 Cr | ₹87.9 Cr | +47.7% |
| EBIT | ₹15.0 Cr | ₹29.9 Cr | ₹48.0 Cr | — | — | +33.7% |
| PAT | ₹3.6 Cr | ₹12.7 Cr | ₹20.2 Cr | ₹23.1 Cr | ₹45.2 Cr | +88.1% |
| EPS (diluted) | ₹1.41 | ₹0.90 | ₹1.40 | — | — | -0.2% |
| CFO | ₹-28.6 Cr | ₹-50.1 Cr | ₹39.9 Cr | ₹-39.1 Cr | ₹45.6 Cr | — |
| CapEx | — | ₹-45.2 Cr | ₹-2.1 Cr | ₹-8.7 Cr | ₹-2.0 Cr | — |
| FCF | — | ₹-95.3 Cr | ₹37.7 Cr | ₹-47.8 Cr | ₹43.6 Cr | — |
| Total Assets | ₹271 Cr | ₹439 Cr | ₹420 Cr | ₹556 Cr | ₹805 Cr | +31.3% |
| Total Debt | — | ₹237 Cr | ₹201 Cr | ₹224 Cr | ₹215 Cr | -2.4% |
| Shareholders' Equity | — | ₹114 Cr | ₹139 Cr | ₹202 Cr | ₹248 Cr | +21.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
MGEL vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
HARRMALAYA HARRMALAYA | — | — | Pending | 9.7% | — |
KNAGRI KNAGRI | — | — | Pending | 10.5% | — |
 SAKUMA SAKUMA | — | — | Pending | 2.1% | — |
 VIKASLIFE VIKASLIFE | — | — | Pending | -2.0% | — |
HALDER HALDER | — | — | Pending | 13.8% | — |
Click a ticker to view its fair-value analysis.
Dividend History
6 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹0.23/sh
Last payout
2025-07-18
₹0.01
Peak payout
₹0.10
Trailing yield
0.07%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. MANGALAM GLOBAL ENT LTD (MGEL.NS) trades at 15.00 vs a model fair value of 22.77, a gap of 51.8%. Piotroski F-score: 6/9. Moat label: Non...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of MGEL →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for MGEL →
Compare
Head-to-head with peers
Compare MGEL side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse MGELNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.